Abstract | INTRODUCTION: METHODS AND DESIGN: ETHICS AND DISSEMINATION: The study is approved by the local ethics committee (NRES Committee London West London: 11/LO/1500) and by the Medicines and Healthcare Products Regulatory Agency (MHRA) (EudraCT nr. 2010-022460-12). The results of the trial will be published according to the CONSORT statement and will be presented at conferences and reported in peer-reviewed journals. TRIAL REGISTRATION: United Kingdom Clinical Research Network (Study ID 12117), http://clinicaltrials.gov (NCT01584453) and Current Controlled Trials (ISRCTN:38736987).
|
Authors | D A Jones, M Andiapen, T J A Van-Eijl, A J Webb, S Antoniou, R J Schilling, A Ahluwalia, A Mathur |
Journal | BMJ open
(BMJ Open)
Vol. 3
Issue 4
( 2013)
ISSN: 2044-6055 [Print] England |
PMID | 23550096
(Publication Type: Journal Article)
|